Poliomyelitis

Poliomyelitis is a highly contagious disease caused by any of the three human poliovirus serotypes, which are part of the enterovirus family. Europe was certified free of poliomyelitis in June 2002. Immunisation and vigilance of the disease continue to ensure the region is free of poliomyelitis. Post-polio syndrome has no defined causal mechanism but it affects between 20% and 80% of patients afflicted with poliomyelitis.

Nen amb simptomes de poliomelitis
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 06.03.2026, 10:41
Share it

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting the motor neurons in the brain and spinal cord, causing progressive paralysis of muscles, including the diaphragm. Early symptoms may include muscle weakness, difficulty speaking or swallowing, and the disease often leads to respiratory failure determining survival. Diagnosis is clinical and by exclusion, and current treatment focuses on symptom management and supportive care in multidisciplinary units.

Persona amb ELA
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 16.03.2026, 15:32
Share it

Chronic fatigue syndrome

Myalgic encephalomyelitis or chronic fatigue syndrome is a chronic, complex and multisystemic disease that can significantly affect functional capacity and daily life. It is characterised by debilitating fatigue that does not improve significantly with rest, post-exertional malaise, sleep disturbances and cognitive difficulties.

Fotografia d'una mitocondria
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 02.11.2026, 11:17
Share it

Rare diseases

Minority diseases, also called rare diseases, are those that affect between 5% and 7% of the population. They are very varied, affecting different parts of the body with a wide range of symptoms that change both between diseases and within the same disease.

It is estimated that some 30 million people in the EU, 3 million in Spain, and around 350,000 in Catalonia suffer from one.

Malalties minoritàries
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 02.12.2025, 12:49
Share it

Alzheimer’s disease

Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide. First described in 1906, it was known for years as senile dementia, but today we know that most cases of senile dementia are AD. WHO data states that it affects over 50 million people worldwide and this is set to triple by 2050. It is the main cause of disability in the elderly and the second specific cause of death in Spain.

Alzheimer
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 03.03.2026, 09:02
Share it

Parkinson's disease

Parkinson's disease is a dysfunction of the basal ganglia caused by degeneration of the cells that produce dopamine in the substantia nigra.

malaltia de parkinson
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 06.03.2026, 09:54
Share it

Neuromuscular and rare diseases

Neuromuscular disease is a chronic illness that results in serious disability, loss of independence, and with significant psychosocial consequences. Respiratory alterations are the main cause of morbidity and mortality in patients with neuromuscular diseases. They are significantly affected by the evolution of the disease and are the reason for multiple hospital admissions where the patient’s life is seriously endangered.

Pacient ingressat
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 05.03.2026, 16:20
Share it

Anticoagulant treatment

Anticoagulant therapy involves the use of medications that reduce the blood’s ability to clot in order to prevent the formation of thrombi. It is used in thromboembolic diseases and in patients at risk of embolism to protect circulation.

Analitiques
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 19.03.2026, 16:07
Share it

Chronic fatigue syndrome

Although there is no treatment to cure chronic fatigue syndrome, a multidisciplinary therapeutic approach can help to improve patients’ quality of life. The aim is to reduce the symptoms of the condition and the chronic problems associated with it in order to overcome possible limitation in daily life.

Fatiga Crònica
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 10.03.2026, 14:08
Share it

Easing migraines

Although a migraine cannot be cured, proper treatment can alleviate pain and prevent future occurrences.

Tractament de la migranya
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 10.03.2026, 13:09
Share it

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.